A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_sessionc03075278f92da8d04c0b064c44e43a9271a68c3): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Inflammatory Marker Market Research Report 2024

img

Global Inflammatory Marker Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Inflammatory Marker Market Research Report 2024

Inflammatory markers are used in the assessment of cancer and other chronic diseases. Inflammation markers raise in the inflammatory conditions.
According to MRAResearch’s new survey, global Inflammatory Marker market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Inflammatory Marker market research.
Key companies engaged in the Inflammatory Marker industry include Merck, Novartis, Thermo Fisher Scientific, Cell Signaling Technology, Boditech Med, PHC Holdings, Abbott, Siemens and BG Medicine, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Inflammatory Marker were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Inflammatory Marker market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Inflammatory Marker market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Novartis
Thermo Fisher Scientific
Cell Signaling Technology
Boditech Med
PHC Holdings
Abbott
Siemens
BG Medicine
Segment by Type
Interlukin
C Reactive Protein
Cellular Adhesion Molecule
Tumor Necrosis Factor-α
Others

Segment by Application


Hospitals
Diagnostic Laboratories
Research Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Inflammatory Marker report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Marker Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Interlukin
1.2.3 C Reactive Protein
1.2.4 Cellular Adhesion Molecule
1.2.5 Tumor Necrosis Factor-α
1.2.6 Others
1.3 Market by Application
1.3.1 Global Inflammatory Marker Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Marker Market Perspective (2018-2033)
2.2 Inflammatory Marker Growth Trends by Region
2.2.1 Global Inflammatory Marker Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Inflammatory Marker Historic Market Size by Region (2018-2023)
2.2.3 Inflammatory Marker Forecasted Market Size by Region (2024-2033)
2.3 Inflammatory Marker Market Dynamics
2.3.1 Inflammatory Marker Industry Trends
2.3.2 Inflammatory Marker Market Drivers
2.3.3 Inflammatory Marker Market Challenges
2.3.4 Inflammatory Marker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Marker Players by Revenue
3.1.1 Global Top Inflammatory Marker Players by Revenue (2018-2023)
3.1.2 Global Inflammatory Marker Revenue Market Share by Players (2018-2023)
3.2 Global Inflammatory Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Marker Revenue
3.4 Global Inflammatory Marker Market Concentration Ratio
3.4.1 Global Inflammatory Marker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Marker Revenue in 2022
3.5 Inflammatory Marker Key Players Head office and Area Served
3.6 Key Players Inflammatory Marker Product Solution and Service
3.7 Date of Enter into Inflammatory Marker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Marker Breakdown Data by Type
4.1 Global Inflammatory Marker Historic Market Size by Type (2018-2023)
4.2 Global Inflammatory Marker Forecasted Market Size by Type (2024-2033)
5 Inflammatory Marker Breakdown Data by Application
5.1 Global Inflammatory Marker Historic Market Size by Application (2018-2023)
5.2 Global Inflammatory Marker Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Inflammatory Marker Market Size (2018-2033)
6.2 North America Inflammatory Marker Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Inflammatory Marker Market Size by Country (2018-2023)
6.4 North America Inflammatory Marker Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inflammatory Marker Market Size (2018-2033)
7.2 Europe Inflammatory Marker Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Inflammatory Marker Market Size by Country (2018-2023)
7.4 Europe Inflammatory Marker Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inflammatory Marker Market Size (2018-2033)
8.2 Asia-Pacific Inflammatory Marker Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Inflammatory Marker Market Size by Region (2018-2023)
8.4 Asia-Pacific Inflammatory Marker Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inflammatory Marker Market Size (2018-2033)
9.2 Latin America Inflammatory Marker Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Inflammatory Marker Market Size by Country (2018-2023)
9.4 Latin America Inflammatory Marker Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inflammatory Marker Market Size (2018-2033)
10.2 Middle East & Africa Inflammatory Marker Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Inflammatory Marker Market Size by Country (2018-2023)
10.4 Middle East & Africa Inflammatory Marker Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Inflammatory Marker Introduction
11.1.4 Merck Revenue in Inflammatory Marker Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Inflammatory Marker Introduction
11.2.4 Novartis Revenue in Inflammatory Marker Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Inflammatory Marker Introduction
11.3.4 Thermo Fisher Scientific Revenue in Inflammatory Marker Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Detail
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology Inflammatory Marker Introduction
11.4.4 Cell Signaling Technology Revenue in Inflammatory Marker Business (2018-2023)
11.4.5 Cell Signaling Technology Recent Development
11.5 Boditech Med
11.5.1 Boditech Med Company Detail
11.5.2 Boditech Med Business Overview
11.5.3 Boditech Med Inflammatory Marker Introduction
11.5.4 Boditech Med Revenue in Inflammatory Marker Business (2018-2023)
11.5.5 Boditech Med Recent Development
11.6 PHC Holdings
11.6.1 PHC Holdings Company Detail
11.6.2 PHC Holdings Business Overview
11.6.3 PHC Holdings Inflammatory Marker Introduction
11.6.4 PHC Holdings Revenue in Inflammatory Marker Business (2018-2023)
11.6.5 PHC Holdings Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Inflammatory Marker Introduction
11.7.4 Abbott Revenue in Inflammatory Marker Business (2018-2023)
11.7.5 Abbott Recent Development
11.8 Siemens
11.8.1 Siemens Company Detail
11.8.2 Siemens Business Overview
11.8.3 Siemens Inflammatory Marker Introduction
11.8.4 Siemens Revenue in Inflammatory Marker Business (2018-2023)
11.8.5 Siemens Recent Development
11.9 BG Medicine
11.9.1 BG Medicine Company Detail
11.9.2 BG Medicine Business Overview
11.9.3 BG Medicine Inflammatory Marker Introduction
11.9.4 BG Medicine Revenue in Inflammatory Marker Business (2018-2023)
11.9.5 BG Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Inflammatory Marker Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Interlukin
Table 3. Key Players of C Reactive Protein
Table 4. Key Players of Cellular Adhesion Molecule
Table 5. Key Players of Tumor Necrosis Factor-α
Table 6. Key Players of Others
Table 7. Global Inflammatory Marker Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Inflammatory Marker Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Inflammatory Marker Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Inflammatory Marker Market Share by Region (2018-2023)
Table 11. Global Inflammatory Marker Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Inflammatory Marker Market Share by Region (2024-2033)
Table 13. Inflammatory Marker Market Trends
Table 14. Inflammatory Marker Market Drivers
Table 15. Inflammatory Marker Market Challenges
Table 16. Inflammatory Marker Market Restraints
Table 17. Global Inflammatory Marker Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Inflammatory Marker Market Share by Players (2018-2023)
Table 19. Global Top Inflammatory Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Marker as of 2022)
Table 20. Ranking of Global Top Inflammatory Marker Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Inflammatory Marker Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Inflammatory Marker Product Solution and Service
Table 24. Date of Enter into Inflammatory Marker Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Inflammatory Marker Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Inflammatory Marker Revenue Market Share by Type (2018-2023)
Table 28. Global Inflammatory Marker Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Inflammatory Marker Revenue Market Share by Type (2024-2033)
Table 30. Global Inflammatory Marker Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Inflammatory Marker Revenue Market Share by Application (2018-2023)
Table 32. Global Inflammatory Marker Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Inflammatory Marker Revenue Market Share by Application (2024-2033)
Table 34. North America Inflammatory Marker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Inflammatory Marker Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Inflammatory Marker Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Inflammatory Marker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Inflammatory Marker Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Inflammatory Marker Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Inflammatory Marker Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Inflammatory Marker Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Inflammatory Marker Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Inflammatory Marker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Inflammatory Marker Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Inflammatory Marker Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Inflammatory Marker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Inflammatory Marker Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Inflammatory Marker Market Size by Country (2024-2033) & (US$ Million)
Table 49. Merck Company Detail
Table 50. Merck Business Overview
Table 51. Merck Inflammatory Marker Product
Table 52. Merck Revenue in Inflammatory Marker Business (2018-2023) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Inflammatory Marker Product
Table 57. Novartis Revenue in Inflammatory Marker Business (2018-2023) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Thermo Fisher Scientific Company Detail
Table 60. Thermo Fisher Scientific Business Overview
Table 61. Thermo Fisher Scientific Inflammatory Marker Product
Table 62. Thermo Fisher Scientific Revenue in Inflammatory Marker Business (2018-2023) & (US$ Million)
Table 63. Thermo Fisher Scientific Recent Development
Table 64. Cell Signaling Technology Company Detail
Table 65. Cell Signaling Technology Business Overview
Table 66. Cell Signaling Technology Inflammatory Marker Product
Table 67. Cell Signaling Technology Revenue in Inflammatory Marker Business (2018-2023) & (US$ Million)
Table 68. Cell Signaling Technology Recent Development
Table 69. Boditech Med Company Detail
Table 70. Boditech Med Business Overview
Table 71. Boditech Med Inflammatory Marker Product
Table 72. Boditech Med Revenue in Inflammatory Marker Business (2018-2023) & (US$ Million)
Table 73. Boditech Med Recent Development
Table 74. PHC Holdings Company Detail
Table 75. PHC Holdings Business Overview
Table 76. PHC Holdings Inflammatory Marker Product
Table 77. PHC Holdings Revenue in Inflammatory Marker Business (2018-2023) & (US$ Million)
Table 78. PHC Holdings Recent Development
Table 79. Abbott Company Detail
Table 80. Abbott Business Overview
Table 81. Abbott Inflammatory Marker Product
Table 82. Abbott Revenue in Inflammatory Marker Business (2018-2023) & (US$ Million)
Table 83. Abbott Recent Development
Table 84. Siemens Company Detail
Table 85. Siemens Business Overview
Table 86. Siemens Inflammatory Marker Product
Table 87. Siemens Revenue in Inflammatory Marker Business (2018-2023) & (US$ Million)
Table 88. Siemens Recent Development
Table 89. BG Medicine Company Detail
Table 90. BG Medicine Business Overview
Table 91. BG Medicine Inflammatory Marker Product
Table 92. BG Medicine Revenue in Inflammatory Marker Business (2018-2023) & (US$ Million)
Table 93. BG Medicine Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inflammatory Marker Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Inflammatory Marker Market Share by Type: 2022 VS 2033
Figure 3. Interlukin Features
Figure 4. C Reactive Protein Features
Figure 5. Cellular Adhesion Molecule Features
Figure 6. Tumor Necrosis Factor-α Features
Figure 7. Others Features
Figure 8. Global Inflammatory Marker Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Inflammatory Marker Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Research Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Inflammatory Marker Report Years Considered
Figure 15. Global Inflammatory Marker Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Inflammatory Marker Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Inflammatory Marker Market Share by Region: 2022 VS 2033
Figure 18. Global Inflammatory Marker Market Share by Players in 2022
Figure 19. Global Top Inflammatory Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Marker as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Inflammatory Marker Revenue in 2022
Figure 21. North America Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Inflammatory Marker Market Share by Country (2018-2033)
Figure 23. United States Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Inflammatory Marker Market Share by Country (2018-2033)
Figure 27. Germany Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Inflammatory Marker Market Share by Region (2018-2033)
Figure 35. China Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Inflammatory Marker Market Share by Country (2018-2033)
Figure 43. Mexico Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Inflammatory Marker Market Share by Country (2018-2033)
Figure 47. Turkey Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Inflammatory Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Merck Revenue Growth Rate in Inflammatory Marker Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Inflammatory Marker Business (2018-2023)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Inflammatory Marker Business (2018-2023)
Figure 52. Cell Signaling Technology Revenue Growth Rate in Inflammatory Marker Business (2018-2023)
Figure 53. Boditech Med Revenue Growth Rate in Inflammatory Marker Business (2018-2023)
Figure 54. PHC Holdings Revenue Growth Rate in Inflammatory Marker Business (2018-2023)
Figure 55. Abbott Revenue Growth Rate in Inflammatory Marker Business (2018-2023)
Figure 56. Siemens Revenue Growth Rate in Inflammatory Marker Business (2018-2023)
Figure 57. BG Medicine Revenue Growth Rate in Inflammatory Marker Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries